Product Code: ETC6181639 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The genome sequencing market in Australia is witnessing rapid growth, driven by falling sequencing costs, government-backed genomics initiatives, and its integration into healthcare systems. Whole genome and exome sequencing are becoming increasingly common in diagnostics for rare diseases and cancer. Initiatives such as the Australian Genomics Health Alliance have played a pivotal role in building infrastructure and encouraging collaboration across research and clinical domains.
Genome sequencing is becoming increasingly mainstream in Australia, with falling costs and expanding clinical utility. Whole genome and whole exome sequencing are being integrated into diagnostic pipelines for rare diseases, cancer, and pharmacogenomics. Public health initiatives are also utilizing genomic data to track disease outbreaks and antimicrobial resistance. The rise of direct-to-consumer genetic testing companies in Australia is further democratizing access to genetic information, contributing to a surge in market growth.
In the Australia Genome Sequencing Market, key challenges include the high cost of whole-genome sequencing despite decreasing prices, limited availability of bioinformatics expertise, and concerns over data privacy and ownership.
The genome sequencing market in Australia is thriving due to falling sequencing costs, rising demand for precision diagnostics, and government-backed initiatives like the Genomics Health Futures Mission. Investment prospects include infrastructure development for sequencing facilities, data analytics platforms, and collaborations for rare disease diagnosis and population genomics projects, all of which are poised for sustained growth.
Genome sequencing activities in Australia are supported by national strategies such as the Genomics Health Futures Mission, which provides funding for research and clinical applications. The Privacy Act 1988 also impacts this market, particularly in the handling and storage of genomic data, ensuring that individuals` genetic information is protected.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Genome Sequencing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Genome Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Genome Sequencing Market - Industry Life Cycle |
3.4 Australia Genome Sequencing Market - Porter's Five Forces |
3.5 Australia Genome Sequencing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Genome Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Australia Genome Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia Genome Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Genome Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of precision medicine and personalized healthcare approaches in Australia |
4.2.2 Growing prevalence of genetic disorders and chronic diseases driving demand for genome sequencing |
4.2.3 Technological advancements in genome sequencing techniques leading to cost reductions and improved accuracy |
4.3 Market Restraints |
4.3.1 High cost associated with genome sequencing procedures may limit market growth |
4.3.2 Limited awareness and understanding among the general population about the benefits of genome sequencing |
4.3.3 Regulatory challenges and data privacy concerns related to genome sequencing data |
5 Australia Genome Sequencing Market Trends |
6 Australia Genome Sequencing Market, By Types |
6.1 Australia Genome Sequencing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Genome Sequencing Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Genome Sequencing Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 Australia Genome Sequencing Market Revenues & Volume, By Systems and Software, 2021- 2031F |
6.1.5 Australia Genome Sequencing Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Australia Genome Sequencing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Australia Genome Sequencing Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.3 Australia Genome Sequencing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.4 Australia Genome Sequencing Market Revenues & Volume, By Microarray, 2021- 2031F |
6.2.5 Australia Genome Sequencing Market Revenues & Volume, By Nucleic Acid Extraction, 2021- 2031F |
6.2.6 Australia Genome Sequencing Market Revenues & Volume, By Purification, 2021- 2031F |
6.2.7 Australia Genome Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Genome Sequencing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia Genome Sequencing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.3.3 Australia Genome Sequencing Market Revenues & Volume, By Drug Discovery and Development, 2021- 2031F |
6.3.4 Australia Genome Sequencing Market Revenues & Volume, By Precision Medicine, 2021- 2031F |
6.3.5 Australia Genome Sequencing Market Revenues & Volume, By Agriculture and Animal Research, 2021- 2031F |
6.3.6 Australia Genome Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Genome Sequencing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Genome Sequencing Market Revenues & Volume, By Research Centers, 2021- 2031F |
6.4.3 Australia Genome Sequencing Market Revenues & Volume, By Academic and Government Institutes, 2021- 2031F |
6.4.4 Australia Genome Sequencing Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.4.5 Australia Genome Sequencing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.4.6 Australia Genome Sequencing Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Genome Sequencing Market Import-Export Trade Statistics |
7.1 Australia Genome Sequencing Market Export to Major Countries |
7.2 Australia Genome Sequencing Market Imports from Major Countries |
8 Australia Genome Sequencing Market Key Performance Indicators |
8.1 Adoption rate of precision medicine practices in healthcare institutions |
8.2 Number of research studies and clinical trials utilizing genome sequencing technology in Australia |
8.3 Investment in RD for genome sequencing technologies |
8.4 Percentage of healthcare professionals trained in interpreting and utilizing genome sequencing data |
8.5 Rate of integration of genome sequencing data into clinical decision-making processes |
9 Australia Genome Sequencing Market - Opportunity Assessment |
9.1 Australia Genome Sequencing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Genome Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Australia Genome Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia Genome Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Genome Sequencing Market - Competitive Landscape |
10.1 Australia Genome Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Australia Genome Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |